NorthStrive Biosciences Signs Licensing Agreement Amendment with MOA Life Plus
NorthStrive Biosciences Inc., a wholly owned subsidiary of PMGC Holdings Inc. (NASDAQ: ELAB), announced today a third amendment to its existing License Agreement with MOA Life Plus Co., Ltd. (KOSDAQ: 142760), a Korean biotechnology company.
The Amendment updates the timing and key development milestones for EL-32 and EL-22 human clinical development programs, aligning the schedule with the parties’ research and development and regulatory expectations.
What is NorthStrive Biosciences?
NorthStrive Biosciences Inc. is a biopharmaceutical company focusing on the development and acquisition of cutting-edge aesthetic medicines. NorthStrive’s lead asset, EL-22, leverages an engineered probiotic approach to address obesity’s pressing issue of preserving muscle while on weight loss treatments, including GLP-1 receptor agonists.
For more information on biopharmaceutical companies and their role in the Indian stock market, visit our website.
What is MOA Life Plus Co. Ltd.?
MOA Life Plus Co. Ltd. is a Korean biotechnology company focused on the research, development, and commercialization of innovative therapeutic and wellness technologies. MOA partners globally to advance scientific innovation across human and animal health applications.
To learn more about biotechnology industry trends and updates, check out our latest articles.
Impact on Indian Investors
The licensing agreement amendment between NorthStrive Biosciences and MOA Life Plus may have implications for Indian investors interested in the biotechnology sector. As the Indian stock market continues to grow, it’s essential for investors to stay informed about the latest developments and trends in the industry.
For more information on Indian stock market trends and analysis, visit our website.
Conclusion
In conclusion, the licensing agreement amendment between NorthStrive Biosciences and MOA Life Plus is a significant development in the biotechnology sector. As the Indian stock market continues to evolve, it’s crucial for investors to stay up-to-date with the latest news and trends in the industry.
Stay ahead of the curve with our expert analysis and insights on the Indian stock market news and trends.